Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell‐Derived Hepatocytes for Cell‐Based Therapy

Recent advancements in the production of hepatocytes from human pluripotent stem cells (hPSC‐Heps) afford tremendous possibilities for treatment of patients with liver disease. Validated current good manufacturing practice (cGMP) lines are an essential prerequisite for such applications but have onl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Stem Cells Transl Med
Auteurs principaux: Blackford, Samuel J.I., Ng, Soon Seng, Segal, Joe M., King, Aileen J.F., Austin, Amazon L., Kent, Deniz, Moore, Jennifer, Sheldon, Michael, Ilic, Dusko, Dhawan, Anil, Mitry, Ragai R., Rashid, S. Tamir
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2018
Sujets:
Pluripotent Stem Cells
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344902/
https://ncbi.nlm.nih.gov/pubmed/30456803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0084
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires